Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 812 results for "ldl"

Amgen Announces Positive Top-Line Results From Phase 3 YUKAWA-...

Study Meets Co-Primary Endpoints of LDL Cholesterol Reduction Amgen (NASDAQ: AMGN) today announced that the Phase 3 YUKAWA-2 (StudY of LDL-Cholesterol ReductionUsing a Monoclonal PCSK9 Antibody in Japanese Patients With Advanced Cardiovascular ... Asian Hospital & Healthcare Management, 16 hours ago

29 images for ldl

MedPage Today, 1 day ago
Stockhouse Bulletin Boards, 1 day ago
Mideast Time, 5 days ago
American Banking News, 5 days ago
American Banking News, 5 days ago, 4 days ago, 2 weeks ago
Glastonbury People, 2 weeks ago
Myrtle Beach Sun News, 2 weeks ago
Guru Focus, 1 week ago

Huge Decreases in LDL Cholesterol With Alirocumab: ODYSSEY

BARCELONA, SPAIN — Treatment with alirocumab (Sanofi/Regeneron Pharmaceuticals), an investigational proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor, resulted in significant reductions in LDL cholesterol in various groups of ...
 Medscape11 hours ago Alirocumab bests ezetimibe for LDL reduction in ODYSSEY studies  Orthopedics Today1 day ago ODYSSEY LONG TERM hints at reduction in CV events with alirocumab  Orthopedics Today14 hours ago Alirocumab drug significantly improves cholesterol levels compared to ezetimibe  News-Medical.Net16 hours ago

Early Hint At Cardiovascular Outcomes With Sanofi's and Regeneron's Rapidly Advancing Cholesterol Drug

Amid a slew of new data demonstrating yet again that PCSK9 inhibitors lower LDL cholesterol drastically and in a wide variety of different patient populations data from one trial offers the first suggestion that the drugs may in fact improve ...
 Forbes.com1 day ago
Asia Net India

Levels of Atherogenic Lipoproteins and Risk for CV Events

Cholesterol Treatment Trialists' (CTT) Collaboration. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 2010;376:167081. Pedersen TR, Olsson AG, ...
 General Medicine eJournal1 day ago High Total and LDL Cholesterol Levels Increased Risk For CKD  Clinician Reviews2 weeks ago September is National Cholesterol Education Month  Redwood Times3 days ago High Cholesterol Foods That Should Avoid  Asia Net India2 weeks ago

The Tide Is Turning For SHLO And LDL

9:11 AM | about stocks: SHLO , LDL (click to enlarge) One of the industries enjoying extended success in the U.S. is the automobile industry. With vehicle sales going through the roof, the rising tide is taking all boats up, including ...
 Seeking Alpha4 days ago
American Banking News

Insider Selling: Dale G. Barnhart Sells 36,100 Shares of Lydall Stock (LDL)

Lydall (NYSE:LDL) CEO Dale G. Barnhart unloaded 36,100 shares of the stock in a transaction that occurred on Wednesday, August 27th. The stock was sold at an average price of $27.45, for a total value of $990,945.00. Following the sale, the chief ...
 American Banking News5 days ago Lydall Insider David H. Williams Unloads 5,137 Shares (LDL)  American Banking News5 days ago Lydall Makes a Move: Up 1.9%  Individual.com1 week ago

LDL Particle Number Measured Using NMR Clinical Analyzer

Image: The Vantera Clinical Analyzer offers the technology that has the ability to directly enumerate low-density lipoprotein (LDL) particle numbers (Photo courtesy of LipoScience). Fully-automated high-throughput nuclear magnetic resonance (NMR) ...
 Lab Medica1 week ago

Top 5 Companies in the Industrial Machinery Industry With the Lowest PEG Ratio (SPW, KAI, CIR, AIMC, LDL)

(Comtex SmarTrend(R)) Below are the three companies in the Industrial Machinery industry with the lowest price to earnings to growth (PEG) ratios. PEG is valuable in assessing the tradeoff between the price of a stock and expected growth. ...
 Individual.com1 week ago
PR Newswire

Sanofi and Regeneron Announce Presentation of Detailed Positive Results from Four Pivotal Alirocumab Trials at ESC Congress 2014

Across these four trials, alirocumab showed significant and sustained reductions in LDL-C over one year on top of standard-of-care statin therapy across different patient types, said Jennifer Robinson, M.D., M.P.H., Director of the Prevention ...
 PR Newswire1 day ago Sanofi and Regeneron Present Detailed Positive Results from Four Pivotal Alirocumab Trials at ESC Congress 2014  EuroInvestor1 day ago Regeneron and Sanofi Announce Presentation of Detailed Positive Results from Four Pivotal Alirocumab Trials at ESC Congress 2014  Benzinga.com1 day ago Sanofi, Regeneron Report Positive Results From Four Pivotal Alirocumab Trials  RTTNews.com1 day ago
MedPage Today

Injection to Lower LDL-C Shows Promise

Meeting Coverage Published: Sep 1, 2014 BARCELONA -- Alirocumab, an investigational, injectable PCSK9 inhibitor, appeared to effectively and safely lower LDL cholesterol when given once every 2 weeks , according to results from multiple trials. ...
 MedPage Today13 hours ago ESC: Evidence Mounts for Injection to Lower LDL-C  MedPage Today1 day ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - ldl
Get updated on latest news & your favorite topics right in your inbox!
More     Less